Literature DB >> 16126959

The stages of type 1A diabetes.

Naru Babaya1, Maki Nakayama, George S Eisenbarth.   

Abstract

We can now predict the development of type 1 diabetes in man because it is a chronic autoimmune disorder with defined stages of disease. We can also readily prevent the disorder in animal models. A major goal is safe prevention in man, and for this we will almost certainly need a better understanding of pathogenesis, coupled with rigorous clinical trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126959     DOI: 10.1196/annals.1361.061

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Changing perspectives in diabetes: their impact on its classification.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2007-04-25       Impact factor: 10.122

Review 2.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

3.  2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.

Authors:  C M Kiekhaefer; B Weber; M Huggins; C Gorichanaz; J A Nehring; H F DeLuca
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  Different immunological responses to early-life antibiotic exposure affecting autoimmune diabetes development in NOD mice.

Authors:  Youjia Hu; Ping Jin; Jian Peng; Xiaojun Zhang; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2016-05-10       Impact factor: 7.094

5.  Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.

Authors:  S Belanger; L-H Tai; S K Anderson; A P Makrigiannis
Journal:  Genes Immun       Date:  2008-06-05       Impact factor: 2.676

6.  Maternal Antibiotic Treatment Protects Offspring from Diabetes Development in Nonobese Diabetic Mice by Generation of Tolerogenic APCs.

Authors:  Youjia Hu; Jian Peng; Ningwen Tai; Changyun Hu; Xiaojun Zhang; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

7.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

Review 8.  Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses.

Authors:  Carla Di Dedda; Debora Vignali; Lorenzo Piemonti; Paolo Monti
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

9.  IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.

Authors:  Qiyuan Tan; Monika Majewska-Szczepanik; Xiaojun Zhang; Marian Szczepanik; Zhiguang Zhou; F Susan Wong; Li Wen
Journal:  Diabetes       Date:  2014-04-02       Impact factor: 9.461

10.  The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression.

Authors:  Tõnis Org; Francesca Chignola; Csaba Hetényi; Massimiliano Gaetani; Ana Rebane; Ingrid Liiv; Uko Maran; Luca Mollica; Matthew J Bottomley; Giovanna Musco; Pärt Peterson
Journal:  EMBO Rep       Date:  2008-02-22       Impact factor: 8.807

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.